AnalystsRoy Buchanan
Roy Buchanan's Stock Forecasts

Analyst Ranking
Top 13%
#612 out of 4997 analysts
Average Return
+16.46%
Win Rate
49%35 out of 72
Risk vs Reward
Poor
Good

Roy Buchanan's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Abivax SaABVX
+1,114.11%$6.38$77.46
2025-01-10 -
2025-08-25
Buy
Cidara Therapeutics IncCDTX
+244.23%$18.63$64.13
2025-05-09 -
2025-08-25
Buy
Cidara Therapeutics IncCDTX
+203.65%$21.12$64.13
2025-04-29 -
2025-08-25
Buy
Cidara Therapeutics IncCDTX
+182.95%$22.67$64.13
2025-06-02 -
2025-08-25
Buy
Cidara Therapeutics IncCDTX
+178.83%$23.00$64.13
2025-03-12 -
2025-08-25
Buy

Roy Buchanan Analyst Color

Get additional color on Roy Buchanan's coverage of popular stocks

Roy Buchanan's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Dynavax Technologies CorpDVAX
8Buy$32.00+207.99%Reiterates
4 days ago
Enanta Pharmaceuticals IncENTA
14Buy$25.00+188.68%Maintains
14 days ago
Cidara Therapeutics IncCDTX
7Buy$66.00+2.92%Maintains
18 days ago
Polypid LtdPYPD
2Buy$14.00+305.80%Maintains
2 months ago
Curevac NvCVAC
9Buy$10.00+85.19%Reiterates
3 months ago
An2 Therapeutics IncANTX
8Buy$2.00+77.78%Maintains
4 months ago
Inovio Pharmaceuticals IncINO
3Buy$18.00+823.08%Reiterates
5 months ago
Esperion Therapeutics IncESPR
3Buy$4.00+86.05%Reiterates
6 months ago
Ironwood Pharmaceuticals IncIRWD
1Buy$14.00+1,002.36%Maintains
7 months ago
Abivax SaABVX
1Buy$33.00-57.40%Reiterates
8 months ago
Hookipa Pharma IncHOOK
2Buy$7.00+694.55%Maintains
9 months ago
Gritstone Bio IncGRTSQ
4Buy$5.00N/AReiterates
a year ago
Arbutus Biopharma CorpABUS
5Buy$5.00N/AMaintains
a year ago
Pardes Biosciences IncPRDS
2Buy$5.00N/AMaintains
2 years ago
Argenx SeARGX
2Buy$448.00N/AMaintains
2 years ago
Cormedix IncCRMD
1Hold$16.00N/AMaintains
2 years ago
Ibio IncIBIO
1Buy$750.00N/AInitiates Coverage On
4 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.